Check out some highlights below from Day 2 at EMUC25, including session reports, webcasts, award winners and photo impressions.
Session report: EMUC25 invokes mindset shift toward sustainability
“Healthcare is the fifth largest producer of greenhouse gases in the world” was a recurring claim in Plenary Session 1: Innovating for a sustainable future in genito-urinary cancer care: The road to 2050. The session featured sustainability in diagnosis and staging, as well as in treatments for radiation therapy, surgery, and medical oncology.
—-
Webcasts of the day
Kidney cancer – localised and locally advanced
RCC with venous thrombosis: optimal imaging for surgical planning and imaging-guided surgery
L. Bianchi, Bologna (IT)
Multidisciplinary case discussion: A stromal tumour in an unexpected location: Prostate
S. Spohn, Freiburg (DE), R. Flippot, Villejuif (FR), J. Gómez Rivas, Madrid (ES), R. Montironi, Ancona (IT), H. Thoeny, Fribourg (CH)
—-
Session report on NMIBC: BCG failure, biomarkers and cost-effective treatments
Non-muscle invasive bladder cancer was featured in Plenary Session 4 today, with an insightful lecture from Dr. Chiara Mercinelli (IT) on ‘Failure after BCG systemic treatment”, Prof. Carmen Jeronimo (PT) presenting on “Urinary biomarkers for monitoring of NMIBC”, and Prof. Ashish Kamat (US) sharing the latest data review of the most cost-effective treatments for NMIBC failure.
—-
Photo impressions of the day
Check out our photo albums of Day 2 of EMUC25 and Abstract Award winners on Facebook. Share your photos and stories on Instagram, LinkedIn, and X as well.
—-
Best EMUC25 Abstracts
O07: Sasanlimab in combination with Bacillus Calmette-Guérin (BCG) in BCG-naive, high-risk non-muscle-invasive bladder cancer (HR NMIBC): Exploratory analysis of patients with very HR (VHR) disease from the phase 3 CREST trial
E.N. Xylinas, Paris (FR)
O05: Treatment with Oxaliplatin or Cisplatin in Combination with Gemcitabine ± Paclitaxel for Platinum-resistant Germ Cell Cancer: Results from a Multi-institutional Retrospective Study
C. Oing, Newcastle upon Tyne (GB)
O06: Association of Pathologic Response and Survival Outcomes in Muscle-Invasive Urothelial Cancer Following Different Neoadjuvant Therapies
Z. Myint, Lexington (US)
—–
EMUC25 Resource Centre
Missed a session? All webcasts, videos, posters and full-text abstracts EMUC25 are available via the Resource Centre.
For participants, viewing EMUC25 webcasts will also earn you CME accreditation. Webcasts are accredited up until Monday, 17 November 2025 (13:00 CET).
